Top 7 manufacturers in Gene Therapy Market
By Prof Researh
Updated 02:20:29 October 14, 2019
.
Updated 02:20:29 October 14, 2019
Prof Resear published a new Market report on Gene Therapy Market. It present the largest 7 manufacruers in Gene Therapy Market. The report is a professional and in-depth study on the current state of the global Gene Therapy market with a focus on the Chinese market. The report provides key statistics on market of Gene Therapy. It is a valuable source of guidance and direction for companies and individuals interested in Gene Therapy industry.
.
Sangamo
Sangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene regulation. Meet the leaders and learn more about Sangamo s latest developments. Oct 11, 2019 · Company Description. Sangamo Therapeutics, Inc. researches and develops transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering o... See the company profile for Sangamo Therapeutics, Inc. (SGMO ) including business summary, industry/sector information, number of employees, business …
Spark Therapeutics
Description Spark Therapeutics , Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. Its products include LUXTURNA (voretigene... Company profile page for Spark Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information. Oct 10, 2019 · Spark Therapeutics , Inc . engages in the research, development, and commercialization of gene therapies . Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and...
Dimension Therapeutics
Company profile page for Dimension Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information. Dimension Therapeutics Inc - Profile Dimension Therapeutics , Inc. engages in the provision of medical development. Its activities include discoveries and development of therapeutic products for... Information on acquisition, funding, cap tables, investors, and executives for Dimension Therapeutics . Use the PitchBook Platform to explore the full profile .
Avalanche Bio
Jul 19, 2019 · Falling masses of snow and ice, avalanches pose a threat to anyone on snowy mountainsides. Beautiful to witness from afar, they can be deadly because of … Avalanche on Simplon Pass (2019) In contrast to powder snow avalanches , wet snow avalanches are a low velocity suspension of snow and water, with the flow confined to the track surface (McClung, first edition 1999, page 108). The low speed of travel is due to the friction between the sliding surface of the track and the water saturated flow. About Avalanche Technology Inc Avalanche Technology , Inc. provides spin programmable storage solutions. The Company offers low power non-volatile magnetic memory technology for scalability, low...
Celladon
View detailed financial information, real-time news, videos, quotes and analysis on Celladon Corp (NASDAQ:CLDN). Explore commentary on Celladon Corp and hear what the experts at TheStreet are ... Celladon Update this profile 2000 FOUNDED. M&A STATUS. 11-20 EMPLOYEES. M&A LATEST DEAL TYPE. $60M LATEST DEAL AMOUNT. Description. Developer of molecular therapies for the treatment of cardiovascular diseases. The companys product candidate is designed to target the key enzyme deficiency in advanced heart failure which regulates calcium ... Nov 18, 2015 · Celladon is registered under the ticker NASDAQ:CLDN . Their stock opened with $8.00 in its Jan 31, 2014 IPO.
Vical Inc.
Company profile page for Vical Inc including stock price, company news, press releases, executives, board members, and contact information Vical Incorporated, incorporated on April 30, 1987, researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and ... View detailed financial information, real-time news, videos, quotes and analysis on Vical Inc. (NASDAQ:VICL ). Explore commentary on Vical Inc . and hear what …
Advantagene
Advantagene (d.b.a. Candel Therapeutics ) is a Boston-area privately held biopharmaceutical company. We are committed to saving, extending and improving the lives of cancer patients and their families through the development and commercialization of innovative and personalized cancer immunotherapies. Company profile page for Advantagene Inc including stock price, company news, press releases, executives, board members, and contact information Skip To Content Skip to content Advantagene . The companys immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity of GMCI which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostate cancer , enabling physicians to treat their patients in an enhanced way.